Sun Pharmaceutical (SUNPHARMA) — Corporate Action

Sun Pharmaceutical declared an interim dividend of ₹11 per share with record date February 5, 2026, payable by February 16, 2026. Q3 FY2026 consolidated net profit grew 16.0% YoY to ₹33,688 million, while nine-month net profit reached ₹87,654 million. Exceptional charges included ₹1,514.9 million SCD-044 drug discontinuation impairment and ₹3,755.3 million New Labour Codes implementation cost. The dividend reflects strong operational performance and shareholder returns.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this corporate action affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 31 January 2026?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 31 January 2026

WIPRO Wipro Limited Corporate Action AMBUJACEM Ambuja Cements Limited Financial Results AMBUJACEM Ambuja Cements Limited Financial Results DELHIVERY Delhivery Limited Financial Results DELHIVERY Delhivery Limited Announcement DELHIVERY Delhivery Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.